FR2542316B1 - Procede de preparation de derives carbapenem, nouveaux intermediaires de synthese et procede de preparation de ces intermediaires - Google Patents
Procede de preparation de derives carbapenem, nouveaux intermediaires de synthese et procede de preparation de ces intermediairesInfo
- Publication number
- FR2542316B1 FR2542316B1 FR8403553A FR8403553A FR2542316B1 FR 2542316 B1 FR2542316 B1 FR 2542316B1 FR 8403553 A FR8403553 A FR 8403553A FR 8403553 A FR8403553 A FR 8403553A FR 2542316 B1 FR2542316 B1 FR 2542316B1
- Authority
- FR
- France
- Prior art keywords
- preparation
- intermediates
- novel synthesis
- carbapenem derivatives
- synthesis intermediates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47137883A | 1983-03-08 | 1983-03-08 | |
US49969183A | 1983-06-07 | 1983-06-07 | |
US55729583A | 1983-12-01 | 1983-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2542316A1 FR2542316A1 (fr) | 1984-09-14 |
FR2542316B1 true FR2542316B1 (fr) | 1988-10-07 |
Family
ID=27413179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8403553A Expired FR2542316B1 (fr) | 1983-03-08 | 1984-03-07 | Procede de preparation de derives carbapenem, nouveaux intermediaires de synthese et procede de preparation de ces intermediaires |
Country Status (31)
Country | Link |
---|---|
JP (1) | JPH05255250A (fr) |
KR (1) | KR900002247B1 (fr) |
AR (1) | AR241016A1 (fr) |
AT (1) | AT387968B (fr) |
AU (2) | AU572124B2 (fr) |
CA (1) | CA1284324C (fr) |
CH (1) | CH658248A5 (fr) |
CY (1) | CY1546A (fr) |
DD (1) | DD228258A5 (fr) |
DE (1) | DE3408347A1 (fr) |
DK (1) | DK140584A (fr) |
ES (2) | ES530337A0 (fr) |
FI (1) | FI840863A (fr) |
FR (1) | FR2542316B1 (fr) |
GB (1) | GB2136802B (fr) |
GR (1) | GR81871B (fr) |
HK (1) | HK82990A (fr) |
HU (1) | HU193895B (fr) |
IE (1) | IE57098B1 (fr) |
IL (1) | IL71149A (fr) |
IT (1) | IT1178465B (fr) |
LU (1) | LU85241A1 (fr) |
NL (1) | NL8400702A (fr) |
NO (1) | NO166038C (fr) |
NZ (1) | NZ207346A (fr) |
OA (1) | OA07674A (fr) |
PT (1) | PT78211B (fr) |
SE (2) | SE8401278L (fr) |
SG (1) | SG35490G (fr) |
YU (2) | YU46147B (fr) |
ZW (1) | ZW3884A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683301A (en) * | 1982-04-08 | 1987-07-28 | Bristol-Myers Company | Carbapenem antibiotics |
US4552696A (en) * | 1982-04-09 | 1985-11-12 | Bristol-Myers Company | Carbapenem antibiotics |
IE851586L (en) * | 1984-07-02 | 1986-01-02 | Interchem Internat S A | I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent |
CA1285940C (fr) * | 1984-07-02 | 1991-07-09 | Merck & Co., Inc. | Carbapenems a substituant heteroarylalkylthio, quaternise en 2 |
US4665169A (en) * | 1985-09-11 | 1987-05-12 | Bristol-Myers Company | Carbapenem antibiotics |
US4880922A (en) * | 1985-11-22 | 1989-11-14 | Bristol-Myers Company | Carbapenems with quaternized heterothioalkylthio substitution at position 2 |
NZ219892A (en) * | 1986-04-15 | 1991-02-26 | Merck & Co Inc | N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof |
NZ237191A (en) * | 1990-02-23 | 1992-12-23 | Sankyo Co | 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions |
US5712267A (en) * | 1991-06-04 | 1998-01-27 | Sankyo Company,. Limited | Carbapenem derivatives, their preparation and their use as antibiotics |
AU2004247462B2 (en) | 2003-06-12 | 2010-09-02 | Btg International Limited | Cyclic hydroxylamine as psychoactive compounds |
FR2921258A1 (fr) * | 2007-09-24 | 2009-03-27 | Oreal | Composition tinctoriale comprenant au moins un precurseur incolore disulfures/thiol, proced de coloration a partir de la composition |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55147284A (en) * | 1979-04-17 | 1980-11-17 | Sanraku Inc | Novel beta-lactam derivative and its preparation |
IE52147B1 (en) * | 1980-03-27 | 1987-07-08 | Merck & Co Inc | 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation |
EP0038869A1 (fr) * | 1980-04-30 | 1981-11-04 | Merck & Co. Inc. | Procédé de préparation de 1-carbapénèmes et intermédiaires pour leur préparation |
EP0060612A1 (fr) * | 1981-02-04 | 1982-09-22 | Beecham Group Plc | Procédé pour la préparation de dérivés de l'azabicyclo-(3.2.0) heptène-2 |
US4552873A (en) * | 1981-08-19 | 1985-11-12 | Sankyo Company Limited | Carbapenem compounds, and compositions containing them |
EP0074599A1 (fr) * | 1981-09-09 | 1983-03-23 | Takeda Chemical Industries, Ltd. | Dérivés de 5,6-cis-carbapénème, leurs préparation et utilisation |
US4552696A (en) * | 1982-04-09 | 1985-11-12 | Bristol-Myers Company | Carbapenem antibiotics |
US4536335A (en) * | 1982-06-18 | 1985-08-20 | Bristol-Myers Company | Carbapenem antibiotics |
-
1984
- 1984-02-29 AR AR295877A patent/AR241016A1/es active
- 1984-02-29 DK DK140584A patent/DK140584A/da not_active Application Discontinuation
- 1984-03-01 NZ NZ207346A patent/NZ207346A/en unknown
- 1984-03-05 FI FI840863A patent/FI840863A/fi not_active Application Discontinuation
- 1984-03-05 NL NL8400702A patent/NL8400702A/xx not_active Application Discontinuation
- 1984-03-05 ZW ZW38/84A patent/ZW3884A1/xx unknown
- 1984-03-05 IL IL71149A patent/IL71149A/xx unknown
- 1984-03-06 CH CH1103/84A patent/CH658248A5/de not_active IP Right Cessation
- 1984-03-06 CA CA000448904A patent/CA1284324C/fr not_active Expired - Fee Related
- 1984-03-06 GR GR73999A patent/GR81871B/el unknown
- 1984-03-07 SE SE8401278A patent/SE8401278L/xx not_active Application Discontinuation
- 1984-03-07 FR FR8403553A patent/FR2542316B1/fr not_active Expired
- 1984-03-07 NO NO840865A patent/NO166038C/no unknown
- 1984-03-07 LU LU85241A patent/LU85241A1/fr unknown
- 1984-03-07 OA OA58247A patent/OA07674A/fr unknown
- 1984-03-07 DD DD84260663A patent/DD228258A5/de not_active IP Right Cessation
- 1984-03-07 AT AT0076984A patent/AT387968B/de not_active IP Right Cessation
- 1984-03-07 IT IT19945/84A patent/IT1178465B/it active
- 1984-03-07 IE IE549/84A patent/IE57098B1/en not_active IP Right Cessation
- 1984-03-07 HU HU84911A patent/HU193895B/hu not_active IP Right Cessation
- 1984-03-07 ES ES530337A patent/ES530337A0/es active Granted
- 1984-03-07 AU AU25360/84A patent/AU572124B2/en not_active Ceased
- 1984-03-07 DE DE19843408347 patent/DE3408347A1/de not_active Withdrawn
- 1984-03-07 PT PT78211A patent/PT78211B/pt unknown
- 1984-03-07 GB GB08405984A patent/GB2136802B/en not_active Expired
- 1984-03-08 KR KR1019840001243A patent/KR900002247B1/ko not_active IP Right Cessation
- 1984-03-08 YU YU42084A patent/YU46147B/sh unknown
- 1984-11-02 ES ES537349A patent/ES537349A0/es active Granted
-
1986
- 1986-03-28 YU YU49486A patent/YU46305B/sh unknown
-
1987
- 1987-07-20 AU AU75924/87A patent/AU605491B2/en not_active Ceased
-
1989
- 1989-04-03 SE SE8901162A patent/SE8901162L/xx not_active Application Discontinuation
-
1990
- 1990-05-19 SG SG35490A patent/SG35490G/en unknown
- 1990-10-11 HK HK829/90A patent/HK82990A/xx unknown
-
1991
- 1991-03-22 CY CY1546A patent/CY1546A/xx unknown
- 1991-09-27 JP JP3274949A patent/JPH05255250A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2645533B1 (fr) | Procede de synthese de sulfonylimidures | |
BE879404A (fr) | Nouveaux derives de la 5h-2,3-benzodiazepine et procede pour la preparation de ces derives | |
PT70804A (fr) | Procede pour la preparation de nouveaux derives heterocicliques | |
FR2542316B1 (fr) | Procede de preparation de derives carbapenem, nouveaux intermediaires de synthese et procede de preparation de ces intermediaires | |
PT73010A (fr) | Procede de synthese de chloroformiates alpha-chlores et nouveaux chloroformiates alpha-chlores | |
MA21348A1 (fr) | Procede pour la preparation de nouveaux derives aminoalcoxyphenyle. | |
RO93218A (fr) | Procede pour la preparation des derives de 2-oxyndole | |
RO96413A (fr) | Procede pour la preparation des derives de thoadiazole | |
MA21148A1 (fr) | Procede de preparation de compose b-lactamique et intermediaires pour sa synthese . | |
FR2654102B1 (fr) | Procede de synthese de derives polyazotes cycliques. | |
MC1691A1 (fr) | Procede de synthese de derives de 4-amino-2-phenylquinolines et intermediaires de synthese | |
MA21167A1 (fr) | Procede de preparation de nouveaux derives oxy-5 du tetrahydrofurane. | |
PT79328A (fr) | Procede de preparation de nouveaux derives de 1-(acetylaminophenyl)-2-amino-propanone | |
RO93563A (fr) | Procede de preparation des derives 3-phenoxyphenyle-propen-yl-cyclopropane | |
MA21499A1 (fr) | Procede de preparation de nouveaux derives de la i-arylsylfonyl 2-pyrrolidinone. | |
FR2547816B1 (fr) | Procede de synthese de l'aspartame | |
FR2557109B1 (fr) | Nouveaux derives de 2-arylbenzothiazoline utiles comme medicaments et procede pour leur preparation | |
FR2555578B1 (fr) | Procede de preparation de derives d'azetidinone | |
FR2562896B1 (fr) | Procede de preparation de derives de 3-exomethylenecephame | |
FR2593506B1 (fr) | Procede de synthese de diorganomonothiophosphinates | |
PT81139A (fr) | Procede de preparation de nouveaux derives de (alcoxy-2) phenylpiperaziniques | |
FR2574792B1 (fr) | Procede pour la preparation de derives de pyrrolidine | |
BE889492A (fr) | Procede de synthese de derives du 3-cetocyclopentene-5-oxy | |
PT75135A (fr) | Procede de preparation de nouveaux derives de benzoyl-phenylpiperidines | |
FR2641784B1 (fr) | Procede de preparation de derives du chromanne et intermediaires de synthese |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |